BEATSON INSTITUTE FOR CANCER RESEARCH
Get an alert when BEATSON INSTITUTE FOR CANCER RESEARCH files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-12-24 (in 7mo)
Last made up 2025-12-10
Watchouts
None on the register
Cash
£15M
-3.6% vs 2024
Net assets
£25M
-3% vs 2024
Employees
316
+3.3% vs 2024
Profit before tax
-£772K
-276.6% vs 2024
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £25,724,000 | £30,651,000 | |
| Operating profit | -£205,000 | -£772,000 | |
| Profit before tax | -£205,000 | -£772,000 | |
| Net profit | -£205,000 | -£772,000 | |
| Cash | £15,614,000 | £15,045,000 | |
| Total assets less current liabilities | £25,440,000 | £24,668,000 | |
| Net assets | £25,440,000 | £24,668,000 | |
| Equity | £25,440,000 | £24,668,000 | |
| Average employees | 306 | 316 | |
| Wages | £12,336,000 | £13,118,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | -0.8% | -2.5% | |
| Net margin | -0.8% | -2.5% | |
| Return on capital employed | -0.8% | -3.1% | |
| Gearing (liabilities / total assets) | 10.4% | 11.5% | |
| Current ratio | 6.92x | 6.34x | |
| Interest cover | -0.97x | -16.78x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Current cash flow projections give the Directors confidence that it is appropriate to prepare the financial statements on a going concern basis.”
Group structure
- BEATSON INSTITUTE FOR CANCER RESEARCH · parent
- Beatson Technology Ltd 100%
Significant events
- “Our 25th Anniversary Beatson International Cancer Conference was an outstanding success and saw the inception of The Sir George Beatson Lecture, which was given by Dr Allan Balmain (UCSF), a world leader in mouse models and former Beatson (CRUK SI) group leader.”
- “We have been working with the Indonesian Government/Embassy towards an MoU with the Institute and its Ministry of Health.”
- “We continue to make considerable advances in our areas of strategic focus, highlighted by the number of ground-breaking primary papers (105) we have published this year”
- “Our joint application to the MRC National Mouse Genetics Network Business Engagement Fund with Oxford Drug Design, a biotechnology company with core expertise in AI drug discovery, was successful.”
- “Our MRC equipment grant application for a contribution to a MALDI matrix sprayer system was also successful (£800k)”
- “Our bids to the Beatson Endowment for a 50% contribution to a Lunaphore spatial biology platform and to UoG/Beatson Cancer Charity for a new 3D spatial genomics platform from Stellaromics (the first in Europe) were successful”
- “Our £5.6 million CRC-STARS proposal to CRUK (Colorectal Cancer - Stratification of Therapies through Adaptive Responses) led by Prof Owen Sansom and Prof Simon Leedham (Oxford) was recommended for funding”
- “the second tranche of MRC funding for the mouse data platform was released to the Institute (£1.8 million).”
- “Prof Crispin Miller and postdoc Dr Holly Hall were also awarded a NC3Rs computational infrastructure grant (£0.5 million)”
- “new start Prof Ram Das Gupta was awarded a Royal Society Wolfson Fellowship (£300k).”
- “Dr Zoi Diamantopoulou's UKRI Future Leaders Fellowship application (Unleashing the power of the circadian rhythm to tackle metastasis) was successful”
- “many of our early career researchers were successful with smaller grant applications and in total were awarded ~£0.57 million.”
- “We made two key strategic appointments. Prof Srikala Raghavan (Chair of Epithelial Immunometabolism) started in October and Prof Ram DasGupta (Chair of Liver Cancer, focusing on human data and in silico work) in January 2025.”
- “Proteomics expert Prof Sara Zanivan left the Institute in November to take up an exciting position at the MD Anderson Cancer Center in Texas.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 50 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| NIVEN, Gary | Secretary | 2017-10-01 | — | — |
| CHADWICK, Rosalie Madeleine | Director | 2017-09-06 | Nov 1977 | British |
| FOULKES, Iain Walter, Dr | Director | 2011-06-30 | Apr 1971 | British |
| IREDALE, John Peter, Professor | Director | 2018-09-10 | Nov 1960 | British |
| KERGON, James Alastair | Director | 2022-06-06 | Dec 1975 | British |
| LYNN, Matthew Richard Fraser | Director | 2026-03-13 | Jun 1980 | British |
| MCINNES, Iain Blair, Professor | Director | 2020-11-20 | Oct 1964 | British |
Show 50 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MCKAIL, Ronald Chalmers | Secretary | 1999-05-18 | 2010-12-13 |
| WINCKLES, Peter David | Secretary | 2010-12-13 | 2017-09-30 |
| WYKE, John Anthony, Professor | Secretary | — | 1999-05-18 |
| AKUSHIE, Rita Kuukua | Director | 2019-01-14 | 2020-09-30 |
| ALWEN, John, Dr | Director | — | 1992-06-17 |
| ANDERSON, Craig | Director | 2011-01-01 | 2022-06-06 |
| ARMITT, Nigel John | Director | 2018-03-07 | 2019-01-11 |
| ARMSTRONG, Ernest Mcalpine, Dr | Director | 2001-07-17 | 2005-04-26 |
| BIRD, Colin Carmichael, Professor | Director | 1992-07-10 | 2007-06-14 |
| BURNS, Henry James Gerard, Dr | Director | 1993-12-10 | 1996-07-18 |
| CARTER, David Craig, Professor | Director | 1996-12-20 | 2000-06-29 |
| CLARK, Lilian, Dr | Director | 2008-03-14 | 2010-09-08 |
| CRITCHLEY, David Royston, Professor | Director | 2006-03-10 | 2007-12-17 |
| CURRIE, Alastair, Sir | Director | — | 1991-12-13 |
| DAVIES, Graeme John, Professor Sir | Director | 1996-12-20 | 2004-12-10 |
| DICKSON, Ian | Director | 2004-12-09 | 2014-05-13 |
| DOMINICZAK, Anna Felicja, Professor Dame | Director | 2019-12-06 | 2020-11-20 |
| DUNSTAN, Diana Rosemary, Dr | Director | 1993-06-17 | 2006-06-12 |
| DUTHIE, Robin, Sir | Director | 1989-05-17 | 1999-05-18 |
| EVANS, Henry John, Professor | Director | — | 1999-05-18 |
| FORWELL, George Dick | Director | — | 1993-06-17 |
| FRASER, William Kerr, Sir | Director | 1992-04-22 | 1996-12-20 |
| GILLIS, Charles Raphael, Professor | Director | 1996-12-20 | 2002-10-11 |
| HASTIE, Nicholas Dixon, Professor | Director | 1999-12-02 | 2007-03-29 |
| HINCE, Trevor Anthony, Dr | Director | 1996-02-23 | 2007-03-29 |
| HORNE, Samantha | Director | 2020-10-01 | 2022-10-17 |
| HUNTER, Archibald Sinclair | Director | 1999-12-02 | 2010-12-31 |
| JACK, Robert Barr, Professor | Director | 1989-05-17 | 2004-06-02 |
| JONES, Nicholas, Professor | Director | 2012-12-10 | 2018-06-08 |
| KEMP, Nigel Harvey, Dr | Director | — | 1989-09-30 |
| KENDELL, Robert Evan, Dr | Director | 1995-11-20 | 1998-06-11 |
| KENYON, Ian Peter | Director | 2013-12-05 | 2017-11-30 |
| KUMAR, Harpal Singh | Director | 2007-06-14 | 2013-03-31 |
| MACDONALD, Iain Smith | Director | — | 1993-06-17 |
| MACKIE, Rona Mcleod, Professor | Director | 1994-01-12 | 2007-03-29 |
| MCVIE, John Gordon, Professor | Director | 1989-10-16 | 1996-05-23 |
| MUIR, Malcolm S, Dr | Director | 1993-11-16 | 1995-06-21 |
| MURDOCH, Kirkland Baird | Director | 2014-05-13 | 2017-03-11 |
| MUSCATELLI, Vito Antonio, Professor | Director | 2015-03-10 | 2019-12-06 |
| RIGBY, Peter William Jack, Professor | Director | 2002-12-20 | 2007-03-29 |
| ROBB, Lynne | Director | 2007-06-14 | 2013-06-10 |
| RUSSELL, Alistair Muir, Sir | Director | 2003-12-10 | 2007-03-29 |
| SHERRATT, David John | Director | — | 1993-11-16 |
| SNEDDON, Peter, Dr | Director | 2010-09-08 | 2011-06-30 |
| VOUSDEN, Karen Heather, Professor | Director | 2002-12-05 | 2007-03-29 |
| WALSH, Adrian Paul | Director | 2024-03-18 | 2026-03-13 |
| WASS, Jonathan Paul | Director | 2022-10-17 | 2024-03-15 |
| WILLIAMS, Alwyn | Director | — | 1991-08-20 |
| WOLF, Charles Roland, Prof | Director | 1998-06-11 | 2007-01-09 |
| WYKE, John Anthony, Professor | Director | 1999-05-18 | 2002-10-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Cancer Research Uk | Corporate entity | Appoints directors, right-to-appoint-and-remove-directors-as-trust | 2016-04-06 | Active |
Filing timeline
Last 20 of 201 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-13 | AP01 | officers | Appoint person director company with name date | |
| 2026-03-13 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-19 | AA | accounts | Accounts with accounts type full | |
| 2025-04-25 | CH01 | officers | Change person director company with change date | |
| 2024-12-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-15 | AA | accounts | Accounts with accounts type full | |
| 2024-03-25 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-25 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-09 | AA | accounts | Accounts with accounts type full | |
| 2022-12-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-26 | AP01 | officers | Appoint person director company with name date | |
| 2022-10-26 | TM01 | officers | Termination director company with name termination date | |
| 2022-06-09 | AA | accounts | Accounts with accounts type full | |
| 2022-06-08 | AP01 | officers | Appoint person director company with name date | |
| 2022-06-07 | TM01 | officers | Termination director company with name termination date | |
| 2021-12-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-06-17 | AA | accounts | Accounts with accounts type full | |
| 2020-12-10 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
+19.2%
£25,724,000 £30,651,000
-
Cash
-3.6%
£15,614,000 £15,045,000
-
Net assets
-3%
£25,440,000 £24,668,000
-
Employees
+3.3%
306 316
-
Operating profit
-276.6%
-£205,000 -£772,000
-
Profit before tax
-276.6%
-£205,000 -£772,000
-
Wages
+6.3%
£12,336,000 £13,118,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers